Modest growth, margin sacrifice ahead, execution uncertain

Filed result shows ₹121.6 Cr (6.7% higher than stated on call)

Q1 ₹843 Cr vs prior year ₹829 Cr = +1.7% (essentially flat); recovery only claimed for June onwards, not verified on call

GNPA 2.7% June 2026 vs 2.6% March 2026 (QoQ worsened); YoY better than June 2025 (~3%), but staff disruptions cited for June spike

8.3% stated; ₹600 Cr NHB facility obtained, ₹106 Cr already availed in early August; plausible stabilization, not yet reduction visible

Delivered NPM 26.0% and ROA 2.9% align with profitability disclosed; spread will compress 10-12 bps going forward for growth/retention

FY27 ₹5,000 Cr disbursement guidance unchanged vs prior FY26 call; AUM 13-14% growth reaffirmed; no guidance upgrade despite optimization narrative.

MD pre-committed to compress spread 10-12 bps in Q2+ for aggressive growth & BT retention, shifting from margin protection to growth-at-cost strategy.

₹843 Cr Q1 vs ₹829 Cr YoY (+1.7%); contradicts 'aggressive' posture; seasonal (April-May staffing disruptions) cited but recovery unverified on call.

New soft (recent slippage) vs chronic (old defaulters) NPA targeting; 1,000-1,100 soft accounts under specialist recovery team; credible approach, not new guidance.

Prioritizing non-TN states (AP, TG, KA, Maharashtra, Gujarat, Rajasthan) while TN remains 57% of book; expansion plan detailed, not quantified with targets.

Cost of funds 8.3% vs bank CASA 3-3.5%; targeting non-salaried/informal borrowers at higher risk, not PSU vanilla segment. No plans to diversify; HFC license restricts scope. Aggressiveness will come from volume, not rate cuts.

Month-end carry-forward ₹35-40 Cr routine cycle. June specifically affected; reported numbers business-as-usual; no material re-statement impact.

Claimed June good, July better, August strong; on track for ₹1,200 Cr+ and ₹5,000 Cr annual. Cannot disclose specific numbers (price-sensitive); confidence based on momentum observation.

April-May staff transfers/promotions disrupted June; isolated incident. Bifurcating NPA into soft (1,000-1,100 recent accounts) and chronic; targeting 50% soft reduction (₹70-75 Cr) + SARFAESI on chronic; goal <2% NPA by March 2027.

IT transformation 2 phases complete; mobile app, API integrations (Perfios/CERSAI/CIBIL) reduce turnaround. Verticalization (separate recoveries, sales, NPA management verticals) replaces generalist branch model. Adding 12-13 branches FY27 focusing AP, TG, KA, west India.

Seasonal; April-May transfers/promotions always slow Q1. Now settled. June strong, July very good, August tracking well. Making up Q1 backlog. ₹5,000 Cr FY27 on track.

Yes, using encashment-basis for 3-4 quarters; only after cheque clears do we book interest and add to AUM. Industry-standard practice.

Q1 flat YoY; recovery claimed for June onward but unverified. Seasonal pattern (April-May disruptions) cited; Q2 target ₹1,200-1,250 Cr to validate momentum.

MD explicitly pre-announced spread sacrifice to fund disbursement growth and arrest BT attrition. NIM 5.4% will face downward pressure from compressed spread.

Refinance facility locked in; balances aggressive pricing strategy by stabilizing funding cost. Further rate reduction negotiated with existing bankers but not quantified.

₹843 Cr Q1 FY27 vs ₹829 Cr Q1 FY26 = +1.7% (essentially flat). MD claimed June onward recovery but no specific numbers disclosed on call. If Q2-Q4 don't accelerate meaningfully, ₹5,000 Cr annual target at risk.

MD pre-announced 10-12 bps spread compression in Q2+ to fund aggressive disbursement growth and arrest BT attrition (June BT spike vs March). Spread 3.4% (June) will compress; ROA/ROE impact unclear if volume doesn't grow proportionally.

Competitor banks/HFCs offering home loans at 8.5-8.75% vs Repco 10.75-11%. MD defended by targeting non-salaried/informal (53.5% of book) with higher underwriting standards. But this segmentation caps addressable market and growth ceiling.

GNPA ratio 2.7% (June 2026) vs 2.6% (March 2026) represents slight QoQ deterioration despite YoY improvement narrative (2.7% June 26 vs ~3% June 25). MD attributed to April-May staff transfers/promotions affecting collection. Recovery to March level (₹405 Cr from ₹427 Cr) targeted by Q2.

Tamil Nadu accounts for 57% of book (implicit ₹9,100+ Cr of ₹15,990 Cr AUM). While diversified by borrower type (53.5% non-salaried, 46.5% salaried), geographic concentration is high. Telangana growing well; rest of states showing uneven growth.

Call disclosed ₹114 Cr PAT (Q1 FY27) vs filed result ₹121.6 Cr (6.7% higher). Encashment-basis for AUM/interest recognition in place for 3-4 quarters; no disclosure of prior-quarter restatement impact. Makes YoY/QoQ comparisons opaque and raises transparency concerns.